Catalyst
Slingshot members are tracking this event:
Ziopharm (ZIOP) estimates completion of Phase 1 study of Autologous CD19-specific T Cells Infusion in patients with Lymphoma in late 2018
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 08, 2019
Occurred Source:
https://ir.ziopharm.com/news-releases/news-release-details/ziopharm-oncology-reports-second-quarter-2019-financial-results
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 1 Study, Cd19, T Cell Infusion, Lymphoma, Interleukin-2, Gene Transfer, Leukapheresis, Stem Cell Transplant, Carmustine, Etoposide, Melphalan, Cytarabine
